EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic epidemiology of Group B Streptococcus colonization among pregnant women in Japan, 2021–2023

Chizu Nishi, Hirofumi Ohtaki iD, Masaki Karino iD, Hiromi Uekita, Ayumi Sano, Tetsuya Kobayashi, Susumu Kaino, Yoshiki Sakamoto, Satoshi Nakano iD

PLOS One · 30.07.2026 · 21 (7) · e0354799

DOI: 10.1371/journal.pone.0354799 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 30.07.2026. Verfasst von Chizu Nishi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Mimihara General Hospital, Sakai, Osaka, Japan. Hauptthemen laut MEDLINE: Streptococcus agalactiae, Streptococcal Infections, Pregnancy Complications, Infectious. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Group B Streptococcus (GBS) colonization in pregnant women is a major risk factor for neonatal diseases; however, molecular epidemiological studies on GBS in Japan remain limited. We characterized 219 GBS isolates recovered from vaginal screening cultures at a general hospital in Osaka Prefecture, Japan between 2021 and 2023. Capsular type, clonal complex/sequence type (CC/ST), virulence factors (pilus islands, Alp family, Srr1/Srr2, and HvgA), and antimicrobial resistance determinants were analyzed using whole-genome sequencing. The predominant lineages were CC19 (27.9%), CC23 (21.9%), and CC1 (21.0%), whereas the hypervirulent CC17 lineage accounted for only 5.5% of isolates. Capsular type Ia, III, and V comprised >60% of the isolates. PI-1/PI-2a (58.0%) was the predominant pilus profile, and rib (35.2%) was the most frequent Alp family gene. The hypervirulence-associated markers hvgA and srr2 were confined to capsular types III/CC17 and IV/CC452. All isolates were susceptible to β-lactams and vancomycin, whereas resistance to macrolides, clindamycin, and levofloxacin was observed at varying frequencies. These findings provide a pre-vaccine molecular baseline for maternal GBS carriage in Japan and highlight srr2 -positive CC452 as a potential emerging lineage of concern.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus agalactiaeStreptococcal InfectionsPregnancy Complications, InfectiousHumansFemaleJapanPregnancyVirulence FactorsWhole Genome SequencingMolecular EpidemiologyAnti-Bacterial AgentsDrug Resistance, BacterialVagina

Substanzen

Virulence FactorsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Mimihara General Hospital, Sakai, Osaka, Japan.
  • Department of Clinical Laboratory Science, Kansai University of Health Sciences, Sennan-gun, Osaka, Japan.
  • Department of Obstetrics and Gynecology, Mimihara General Hospital, Sakai, Osaka, Japan.
  • Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Higashimurayama-shi, Tokyo, Japan.

ORCID-Profile: Hirofumi Ohtaki, Masaki Karino, Satoshi Nakano

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Nishi, C., Ohtaki, H., Karino, M., Uekita, H., Sano, A., Kobayashi, T., Kaino, S., Sakamoto, Y., & Nakano, S. (2026). Genomic epidemiology of Group B Streptococcus colonization among pregnant women in Japan, 2021–2023. PLOS One, 21(7), e0354799. https://doi.org/10.1371/journal.pone.0354799

Vancouver

Nishi C, Ohtaki H, Karino M, Uekita H, Sano A, Kobayashi T, et al. Genomic epidemiology of Group B Streptococcus colonization among pregnant women in Japan, 2021–2023. PLOS One. 2026;21(7):e0354799. doi:10.1371/journal.pone.0354799

BibTeX
@article{Nishi2026,
  author = {Nishi, Chizu and Ohtaki, Hirofumi and Karino, Masaki and Uekita, Hiromi and Sano, Ayumi and Kobayashi, Tetsuya and Kaino, Susumu and Sakamoto, Yoshiki and Nakano, Satoshi},
  title = {Genomic epidemiology of Group B Streptococcus colonization among pregnant women in Japan, 2021–2023},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {7},
  pages = {e0354799},
  doi = {10.1371/journal.pone.0354799}
}
Kostenlos starten →